A5084944795- Metabolism, Diabetes, and Cancer
- Cancer, Hypoxia, and Metabolism
- Diet and metabolism studies
- Liver Disease Diagnosis and Treatment
- Cancer Cells and Metastasis
- Diet, Metabolism, and Disease
- Genomics, phytochemicals, and oxidative stress
University of Illinois Urbana-Champaign
2021-2023
Abstract Estrogen receptor–positive (ER+) metastatic tumors contribute to nearly 70% of breast cancer–related deaths. Most patients with ER+ cancer (MBC) undergo treatment the estrogen receptor antagonist fulvestrant as standard care. Yet, among such patients, metastasis in liver is associated reduced overall survival compared other sites. The factors underlying responsiveness metastases ER-targeting agents remain unknown, impeding development more effective approaches improve outcomes for...
Abstract Estrogen receptor-positive (ER + ) metastatic tumors contribute to nearly 70% of breast cancer-related deaths. Most patients with ER cancer (MBC) undergo treatment the estrogen receptor antagonist fulvestrant (Fulv) as standard-of-care. Yet, among such patients, metastasis in liver is associated reduced overall survival compared other sites. The factors underlying responsiveness metastases ER-targeting agents remain unknown, impeding development more effective approaches improve...
<div>Abstract<p>Estrogen receptor–positive (ER<sup>+</sup>) metastatic tumors contribute to nearly 70% of breast cancer–related deaths. Most patients with ER<sup>+</sup> cancer (MBC) undergo treatment the estrogen receptor antagonist fulvestrant as standard care. Yet, among such patients, metastasis in liver is associated reduced overall survival compared other sites. The factors underlying responsiveness metastases ER-targeting agents remain unknown,...
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
<div>Abstract<p>Estrogen receptor–positive (ER<sup>+</sup>) metastatic tumors contribute to nearly 70% of breast cancer–related deaths. Most patients with ER<sup>+</sup> cancer (MBC) undergo treatment the estrogen receptor antagonist fulvestrant as standard care. Yet, among such patients, metastasis in liver is associated reduced overall survival compared other sites. The factors underlying responsiveness metastases ER-targeting agents remain unknown,...
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Supplementary Figure from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy